James Leonardo
Hematology & Oncology · Chambersburg, PANPI 1285699017
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $3,902 of the $4,619 with a category attached, or 84.5%. It is spread thinly across 38 manufacturers, the largest accounting for just 16.4% — the pattern of someone who eats at a lot of different presentations.
Across 219 payments — averaging $21.09 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novartis$758
- Pfizer$448
- Amgen$421
- AstraZeneca$403
- Merck$273
- Bristol Myers Squibb$203
- plus $2K from 32 others
Across 4 payments — averaging $9304.17 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- AstraZeneca$37K
What the payments were for
- Speaking & faculty fees$2004%
- Food & beverage$3,90284%
- Education$180%
- Other$49911%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novartis | 23 | $758 |
| Pfizer | 22 | $448 |
| Amgen | 17 | $421 |
| AstraZeneca | 22 | $403 |
| Merck | 17 | $273 |
| Bristol Myers Squibb | 12 | $203 |
| Novocure GmbH | 1 | $200 |
| Regeneron Healthcare Solutions, Inc. | 6 | $157 |
| Sanofi | 7 | $145 |
| Puma Biotechnology, Inc. | 7 | $143 |
| Lilly USA, LLC | 10 | $138 |
| Pharmacyclics LLC, An Abbvie Company | 8 | $127 |
| Boehringer Ingelheim | 5 | $98 |
| Dova Pharmaceuticals | 5 | $96 |
| Eisai Inc. | 5 | $95 |
| Seagen Inc. | 5 | $93 |
| Exelixis Inc. | 4 | $82 |
| Genentech USA, Inc. | 6 | $78 |
| Daiichi Sankyo Inc. | 4 | $70 |
| E.r. Squibb & Sons, L.L.C. | 4 | $70 |
| Johnson & Johnson | 3 | $61 |
| Beigene USA, Inc. | 3 | $53 |
| Incyte Corporation | 2 | $41 |
| Bayer | 2 | $38 |
| AbbVie | 2 | $38 |
| EMD Serono, Inc. | 2 | $37 |
| Servier Pharmaceuticals LLC | 2 | $37 |
| Clovis Oncology, Inc. | 2 | $29 |
| Blueprint Medicines Corporation | 1 | $24 |
| GSK | 2 | $24 |
| Adaptive Biotechnologies Corporation | 1 | $23 |
| Rigel Pharmaceuticals, Inc. | 1 | $20 |
| Myriad Genetic Laboratories, Inc. | 1 | $17 |
| Astellas Pharma US Inc | 1 | $17 |
| Karyopharm Therapeutics Inc. | 1 | $16 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $15 |
| Epizyme, Inc. | 1 | $15 |
| Taiho Oncology, Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- TALZENNA$125
How this compares
$4,619 in reported general payments places this provider in the 65th percentile of 682 hematology & oncology providers in Pennsylvania.
Other hematology & oncology in Chambersburg
- Salman FazalPittsburgh$2.3M
- Cyrus KhanPittsburgh$1.9M
- Usama GergisAllentown$1.2M
- Kit LuHarrisburg$810K
- Henry FungPhiladelphia$730K
- Alexander BarsoukPittsburgh$674K
- Abdalla SholiWilliamsport$576K
- Charu AggarwalPhiladelphia$541K
- Tracey EvansEast Norriton$500K
- Corey LangerPhiladelphia$492K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.